Back
Status filter :


RESET SEARCH AND FILTERS
Gastro-intestinal system
Gastro-intestinal system / Diarrhoea
  codeine phosphate On Formulary
CODEINE PHOSPHATE

Chronic diarrhoea in children >12years without any respiratory issues

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Paediatric Acute Sickle Cell Pain Pathway

See attached

Paediatric Acute Pain Pathway

See attached

  loperamide hydrochloride On Formulary
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

LOPERAMIDE HYDROCHLORIDE

For chronic diarrhoea, irritable bowel where diarrhoea is predominant, and Short Bowel Syndrome

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Orodispersible tablet
Imodium (McNeil Products Ltd) On Formulary
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

see attached

The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Gastro-intestinal system / Exocrine pancreatic insufficiency
  pancreatin On Formulary
  Gastro-resistant capsule
Creon (Viatris UK Healthcare Ltd) On Formulary
  Gastro-resistant granules
Creon (Viatris UK Healthcare Ltd) On Formulary
Gastro-intestinal system / Obesity
  orlistat On Formulary
Orlistat Use in Childhood Obesity June 2015

Gastro-intestinal system / Inflammatory bowel disease
  Vedolizumab Hospital Only
Paediatric Ulcerative Colitis aged 3-18yrs

4th line treatment for paediatric ulcerative colitis (see attached algorithm below)

 

IV infusion loading dose 6mg/kg (max dose 300mg) at week 0, 2 and 6 then maintenance every 8 weeks.

Blueteq form required for post-pubescent patients - check paediatric gastroenterology pharmacist is aware of all new patients starting treatment.

 

 

Paediatric Crohn's Disease

Post-pubescent patients only - Blueteq form required. Dosing as for ulcerative colitis.

  adalimumab On Formulary NICE TA373
NICE TA455
ADALIMUMAB

Acute Crohn's disease in combination with Methotrexate or Azathioprine
 

https://pathways.nice.org.uk/pathways/crohns-disease

  azathioprine Hospital Only
Difficult to Obtain Letter

see attached

AZATHIOPRINE

CYTOTOXIC- tablets should not be broken, crushed or dissolved

Unresponsive or chronically active Crohn's disease

Severe Ulcerative Colitis/ Crohn's disease incombination with steroids

Alternative to aminosalicylates-for resistant or frequently relapsing cases of Ulcerative Colitis/Crohn's disease

Alternative to metronidazole/Ciprofloxacin for fistulating Crohn's disease
 

https://pathways.nice.org.uk/pathways/crohns-disease

https://pathways.nice.org.uk/pathways/ulcerative-colitis

  balsalazide sodium On Formulary
BALSALAZIDE SODIUM

http://publications.nice.org.uk/ulcerative-colitis-cg166

  beclometasone dipropionate On Formulary
  budesonide On Formulary
Budesonide Oral Viscous - For Eosinophilic Oesophagitis

Use budesonide nebuliser solution according to guidelines attached.

  ciclosporin On Formulary
CICLOSPORIN

For Hospital Use Only

CICLOSPORIN

Ciclosporin - last line for Ulcerative Colitis not responsive to aminosalicylates & corticosteroids

Use Sandimmun brand for acute Ulcerative Colitis

Use Neoral brand for maintenance Ulcerative Colitis
 

https://pathways.nice.org.uk/pathways/ulcerative-colitis

  Solution for infusion
Sandimmun (Novartis Pharmaceuticals UK Ltd) On Formulary
Sandimmun®

For Hospital Use Only - Unless part of SCG

Acute Ulcerative Colitis

  golimumab Off Formulary
  hydrocortisone On Formulary
HYDROCORTISONE


Alternative to prednisolone for severe Inflammatory Bowel Disease OR disease not responding to oral corticosteroid

Acute treatment of Ulcerative Colitis and Crohn's disease and for maintenance in 'nil-by mouth' patients on prednisolone


https://pathways.nice.org.uk/pathways/ulcerative-colitis 

https://pathways.nice.org.uk/pathways/crohns-disease

  infliximab On Formulary NICE TA187
NICE TA329
Use of Infliximab in Inflammatory Bowel Disorders

see attached

Bart's Health - Guidance for use of Infliximab

see attached

INFLIXIMAB

Severe active Ulcerative Colitis/Crohn's disease

Maintenance of Ulcerative Colitis/Crohn's disease in patients that respond to the initial induction course

Last line for fistulating Crohn's disease refractory to conventional treatment

http://publications.nice.org.uk/ulcerative-colitis-cg166
http://publications.nice.org.uk/crohns-disease-cg152

  mercaptopurine On Formulary
MERCAPTOPURINE

CYTOTOXIC- tablets should not be broken, crushed or dissolved

Unresponsive or chronically active Crohn's disease

Alternative to aminosalicylates-for resistant or frequently relapsing cases of Ulcerative Colitis/Crohn's disease

Second line if Azathioprine not tolerated

Alternative to metronidazole/Ciprofloxacin for fistulating Crohn's disease

  mesalazine On Formulary
Drugs Used in Paediatric Inflammatory Bowel Disease

MESALAZINE

*Specify preparation by brand name*
 Use most cost-effective brand for initiation of treatment (currently Salofalk)


used for chronic bowel disorders (Ulcerative Colitis/ Crohn's disease
 
https://pathways.nice.org.uk/pathways/ulcerative-colitis

https://pathways.nice.org.uk/pathways/crohns-disease

  Gastro-resistant tablet
Salofalk (Dr. Falk Pharma UK Ltd) On Formulary
NICE Guidance

*Specify preparation by brand name*
 Use most cost-effective brand for initiation of treatment (currently Salofalk)


used for chronic bowel disorders (Ulcerative Colitis/ Crohn's disease

http://publications.nice.org.uk/ulcerative-colitis-cg166
http://publications.nice.org.uk/crohns-disease-cg152

  Modified-release granules
Pentasa (Ferring Pharmaceuticals Ltd) On Formulary
NICE Guidance

*Specify preparation by brand name*
 Use most cost-effective brand for initiation of treatment (currently Salofalk)


used for chronic bowel disorders (Ulcerative Colitis/ Crohn's disease

http://publications.nice.org.uk/ulcerative-colitis-cg166
http://publications.nice.org.uk/crohns-disease-cg152

Salofalk (Dr. Falk Pharma UK Ltd) On Formulary
NICE Guidance

*Specify preparation by brand name*
 Use most cost-effective brand for initiation of treatment (currently Salofalk)


used for chronic bowel disorders (Ulcerative Colitis/ Crohn's disease

http://publications.nice.org.uk/ulcerative-colitis-cg166
http://publications.nice.org.uk/crohns-disease-cg152

  Suppository
Pentasa (Ferring Pharmaceuticals Ltd) On Formulary
NICE Guidance

*Specify preparation by brand name*
 Use most cost-effective brand for initiation of treatment (currently Salofalk)


used for chronic bowel disorders (Ulcerative Colitis/ Crohn's disease

http://publications.nice.org.uk/ulcerative-colitis-cg166
http://publications.nice.org.uk/crohns-disease-cg152

Salofalk (Dr. Falk Pharma UK Ltd) On Formulary
NICE Guidance

*Specify preparation by brand name*
 Use most cost-effective brand for initiation of treatment (currently Salofalk)


used for chronic bowel disorders (Ulcerative Colitis/ Crohn's disease

http://publications.nice.org.uk/ulcerative-colitis-cg166
http://publications.nice.org.uk/crohns-disease-cg152

  methotrexate On Formulary
Methotrexate

Hospital Use Only

Monitoring blood values while on methotrexate

see attached

Methotrexate Blood Monitoring Schedule

see attached

METHOTREXATE

*ONCE WEEKLY dosing*

Unresponsive or chronically active Crohn's disease

Last line for Crohn's disease when azathioprine and mercaptopurine are ineffective
 

https://pathways.nice.org.uk/pathways/crohns-disease

  prednisolone On Formulary
Cystic Fibrosis & non-CF Prescribing Pathway

see attached

PREDNISOLONE


First line for Inflammatory Bowel Disease in conjunction with oral aminosalicylate for refractory or moderate disease

NOT for use as maintenance therapy unless weaning off or waiting for azathioprine to work, or for auto-immune hepatitis

Chronic bowel disorders (Ulcerative Colitis/ Crohn's disease)
 

https://pathways.nice.org.uk/pathways/ulcerative-colitis

https://pathways.nice.org.uk/pathways/crohns-disease

 

Prednisolone soluble tablets

Non-formulary (except long term patients with compliance issues)

  sulfasalazine On Formulary
SULFASALAZINE

Chronic bowel disorders (Ulcerative Colitis/ Crohn's disease)

 https://pathways.nice.org.uk/pathways/ulcerative-colitis


https://pathways.nice.org.uk/pathways/crohns-disease

 

  Gastro-resistant tablet
Sulfasalazine (Non-proprietary) On Formulary
NICE Guidance

Chronic bowel disorders (Ulcerative Colitis/ Crohn's disease)

http://publications.nice.org.uk/ulcerative-colitis-cg166
http://publications.nice.org.uk/crohns-disease-cg152

  Oral suspension
Sulfasalazine (Non-proprietary) On Formulary
NICE Guidance

Chronic bowel disorders (Ulcerative Colitis/ Crohn's disease)

http://publications.nice.org.uk/ulcerative-colitis-cg166
http://publications.nice.org.uk/crohns-disease-cg152

  ustekinumab Hospital Only NICE TA455
Paediatric Crohn’s disease aged 3-18yrs

4th line treatment (see attached algorithm below)

IV infusion loading dose 6mg/kg at week 0, followed by 8 weekly subcutaneous injection 45 mg (≤ 45kg) or 90 mg (>45kg) – weight dependent

 

DTC DEC 2021

Approval recevied to increase dosing frequency-  schedule to 6 weekly for 1 patient/year and 4 weekly for 1 patient every 2 years

July 2024 - Ustekinumab for refractory Crohn’s disease in pre-pubescent children

The licence has been extened for ustekinumab in children aged 6 years and over for paediatric plaque psoriasis, application of the Commissioning Medicines for Children policy also enables access to children aged 6 years and over with Crohn’s disease.

Gastro-intestinal system / Irritable bowel syndrome
  mebeverine hydrochloride On Formulary
  Modified-release capsule
Colofac MR (Viatris UK Healthcare Ltd) On Formulary
  Oral suspension
Mebeverine hydrochloride (Non-proprietary) On Formulary
  peppermint oil On Formulary
  Modified-release capsule
Colpermin (Johnson & Johnson Ltd) On Formulary
Gastro-intestinal system / Bowel cleansing
  bisacodyl On Formulary
Barts Health Guideline - Management of Constipation in Children

Difficult to Obtain Letter

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

BISACODYL

 

https://www.nice.org.uk/guidance/cg99

  Gastro-resistant tablet
Bisacodyl (Non-proprietary) On Formulary
  docusate sodium On Formulary
Paediatric Oncology Local Guidelines July 14


Barts Health Guideline - Management of Constipation in Children

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

DOCUSATE SODIUM

https://www.nice.org.uk/guidance/cg99

  Oral solution
Docusol (Typharm Ltd) On Formulary
Paediatric Oncology Local Guidelines July 14


The Association of Paediatric Palliative Medicine Formulary - 2015

Barts Health Guideline - Management of Constipation in Children

  macrogol 3350 with anhydrous sodium sulfate, potassium chloride, sodium bicarbonate and sodium chloride On Formulary
Barts Health Bowel Cleansing guidelines

BH Bowel Cleansing guidelines

Bowel Cleansing

Bowel Cleansing

  magnesium citrate with sodium picosulfate On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  meglumine amidotrizoate with sodium amidotrizoate On Formulary
  Oral solution
Gastrografin (Bayer Plc) On Formulary
Gastro-intestinal system / Constipation
  bisacodyl On Formulary
Barts Health Guideline - Management of Constipation in Children

Difficult to Obtain Letter

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

BISACODYL

 

https://www.nice.org.uk/guidance/cg99

  Gastro-resistant tablet
Bisacodyl (Non-proprietary) On Formulary
  docusate sodium On Formulary
Paediatric Oncology Local Guidelines July 14


Barts Health Guideline - Management of Constipation in Children

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

DOCUSATE SODIUM

https://www.nice.org.uk/guidance/cg99

  Oral solution
Docusol (Typharm Ltd) On Formulary
Paediatric Oncology Local Guidelines July 14


The Association of Paediatric Palliative Medicine Formulary - 2015

Barts Health Guideline - Management of Constipation in Children

  glycerol On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

GLYCEROL

https://www.nice.org.uk/guidance/cg99

  Suppository
Glycerol (Non-proprietary) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

  ispaghula husk On Formulary
ISPAGHULA HUSK

Irritable Bowel Syndrome if increased dietary fibre is required

  lactulose On Formulary
Paediatric Oncology Local Guidelines July 14


Barts Health Guideline - Management of Constipation in Children

Cystic Fibrosis & non-CF Prescribing Pathway

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

LACTULOSE

https://www.nice.org.uk/guidance/cg99
 
Avoid in Irritable Bowel Syndrome due to bloating

  Oral solution
Lactulose (Non-proprietary) On Formulary
Paediatric Oncology Local Guidelines July 14

see attached

Barts Health Guideline - Management of Constipation in Children

see attached

The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

  macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride On Formulary
  senna On Formulary
Paediatric Oncology Local Guidelines July 14


Barts Health Guideline - Management of Constipation in Children

The Association of Paediatric Palliative Medicine Formulary - 2017

see link

SENNA

https://www.nice.org.uk/guidance/cg99

  sodium picosulfate On Formulary
Paediatric Oncology Local Guidelines July 14


Barts Health Guideline - Management of Constipation in Children

Paediatric Oncology Local Guidelines July 14

see attached

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

SODIUM PICOSULFATE

https://www.nice.org.uk/guidance/cg99

  Oral solution
Sodium picosulfate (Non-proprietary) On Formulary
Paediatric Oncology Local Guidelines July 14


Barts Health Guideline - Management of Constipation in Children

see attached

Gastro-intestinal system / Food allergy
  chlorphenamine maleate On Formulary
  Oral solution
Chlorphenamine maleate (Non-proprietary) On Formulary
Paediatric Oncology Local Guidelines July 14

see attached

  sodium cromoglicate On Formulary
Gastro-intestinal system / Gastro-intestinal smooth muscle spasm
  dicycloverine hydrochloride On Formulary
  Oral solution
Dicycloverine hydrochloride (Non-proprietary) On Formulary
  hyoscine butylbromide On Formulary
HYOSCINE BUTYLBROMIDE

Hyoscine butylbromide oral doses commonly used at Barts Health:
5-10years - 5mg 3-4 times a day
>10years - 10mg 3-4 times a day

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Solution for injection
Buscopan (Sanofi Consumer Healthcare) On Formulary
  mebeverine hydrochloride On Formulary
  Modified-release capsule
Colofac MR (Viatris UK Healthcare Ltd) On Formulary
  Oral suspension
Mebeverine hydrochloride (Non-proprietary) On Formulary
Gastro-intestinal system / Biliary disorders
  cholic acid Hospital Only
  colestyramine On Formulary
COLESTYRAMINE

Diarrhoea resulting from the loss of bile-salt absorption

  ursodeoxycholic acid On Formulary
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

CF Prescribing Pathway Final Version 5 Dec 2015 SCG

URSODEOXYCHOLIC ACID

Short Bowel Syndrome

Intestinal failure liver disease

  Oral suspension
Ursofalk (Dr. Falk Pharma UK Ltd) On Formulary
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

see attached

Gastro-intestinal system / Hepatic encephalopathy
  lactulose On Formulary
Paediatric Oncology Local Guidelines July 14


Barts Health Guideline - Management of Constipation in Children

Cystic Fibrosis & non-CF Prescribing Pathway

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

LACTULOSE

https://www.nice.org.uk/guidance/cg99
 
Avoid in Irritable Bowel Syndrome due to bloating

  Oral solution
Lactulose (Non-proprietary) On Formulary
Paediatric Oncology Local Guidelines July 14

see attached

Barts Health Guideline - Management of Constipation in Children

see attached

The Association of Paediatric Palliative Medicine Formulary - 2015

see attached

Gastro-intestinal system / Oesophageal varices
  terlipressin acetate On Formulary
For Hospital Use Only



On formulary:
- Glypressin injection 1mg

  Solution for injection
Terlipressin acetate (Non-proprietary) On Formulary
Glypressin®

For Hospital Use Only

On formulary:
- Glypressin injection 1mg

  vasopressin On Formulary
Synthetic vasopressin

Injection Formulation is Hospital Use Only

  Solution for injection
Vasopressin (Non-proprietary) On Formulary
Note

Injection Formulation is Hospital Use Only

Gastro-intestinal system / Dyspepsia
  magnesium trisilicate with magnesium carbonate and sodium bicarbonate On Formulary
MAGNESIUM TRISILICATE

For primary care only

  sodium alginate with potassium bicarbonate
  Oral suspension
Gaviscon Advance (Reckitt Benckiser Healthcare (UK) Ltd) On Formulary
Cystic Fibrosis & non-CF Prescribing Pathway

CF & non CF Prescribing Pathway

Gaviscon® Advance

For use in Primary care only

Limted evidence to support use

Gastro-intestinal system / Gastric and duodenal ulceration
  esomeprazole Off Formulary
  Gastro-resistant tablet
Esomeprazole (Non-proprietary) Off Formulary
Nexium (Grunenthal Ltd, Haleon UK Trading Ltd) Off Formulary
  Gastro-resistant capsule
Esomeprazole (Non-proprietary) Off Formulary
Emozul (Krka UK Ltd) Off Formulary
  Powder for solution for injection
Esomeprazole (Non-proprietary) Off Formulary
Nexium (Grunenthal Ltd) Off Formulary
  lansoprazole On Formulary
CF Prescribing Pathway Final Version 5 Dec 2015 SCG

Cystic Fibrosis & non-CF Prescribing Pathway

Barts Health Oral Proton Pump Inhibitor use in Children Guideline

LANSOPRAZOLE

https://pathways.nice.org.uk/pathways/acute-upper-gastrointestinal-bleeding

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Orodispersible tablet
Zoton FasTab (Pfizer Ltd) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

Barts Health Oral Proton Pump Inhibitor use in Children Guideline

Zoton®

Alternative to lansoprazole capsules

See PPI protocol

  omeprazole On Formulary
Barts Health Paediatric H pylori eradication Guideline

Seek advice from tertiary Paediatric Gastro team before initiating H pylori eradication treatment.

Barts Health Oral Proton Pump Inhibitor use in Children Guideline

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

CF Prescribing Pathway Final Version 5 Dec 2015 SCG

Cystic Fibrosis & non-CF Prescribing Pathway

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached 

OMEPRAZOLE

For NICE guidance on management of upper GI bleeding in children over 16 years:

https://pathways.nice.org.uk/pathways/acute-upper-gastrointestinal-bleeding

  ranitidine On Formulary
CF Prescribing Pathway Final Version 5 Dec 2015 SCG

RANITIDINE

First line for gastro-oesophageal reflux disease

http://publications.nice.org.uk/acute-upper-gastrointestinal-bleeding-management-cg141

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

see attached

Cystic Fibrosis & non-CF Prescribing Pathway

see attached

RANITIDINE

First line for gastro-oesophageal reflux disease
 
https://pathways.nice.org.uk/pathways/acute-upper-gastrointestinal-bleeding

Ranitidine Shortage Nov 2019

Please see memo for management during shortage at Barts Health

  sucralfate On Formulary
SUCRALFATE

Last line for haematemesis despite optimal treatment with other drugs

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

Gastro-intestinal system / Gastro-oesophageal reflux disease
  esomeprazole Off Formulary
ESOMEPRAZOLE

Only the injection formulation is on formulary, and is restricted for use in Paediatrics.

Injection Formulation is a Hospital Only drug

Following the discontinuation of omeprazole bolus injection, we have switched to esomeprazole injection as the IV Proton Pump Inhibitor (PPI) of choice in paediatrics.

Recommended dosing:
Under 1 year: 0.5 – 1mg/kg once daily

1 – 11 years:
Body-weight < 20kg: 10mg once daily
Body-weight ≥ 20kg: 10 – 20mg once daily

12 – 18 years: 20 – 40mg once daily

Barts Health Oral Proton Pump Inhibitor use in Children Guideline

see attached

  Gastro-resistant tablet
Esomeprazole (Non-proprietary) Off Formulary
Nexium (Grunenthal Ltd, Haleon UK Trading Ltd) Off Formulary
  Gastro-resistant capsule
Esomeprazole (Non-proprietary) Off Formulary
Emozul (Krka UK Ltd) Off Formulary
  Powder for solution for injection
Esomeprazole (Non-proprietary) Off Formulary
Esomeprazole

Only the injection formulation is on formulary, and is restricted for use in Paediatrics.

Injection Formulation is a Hospital Only drug

Barts Health Oral Proton Pump Inhibitor use in Children Guideline

see attached

Nexium (Grunenthal Ltd) Off Formulary
  lansoprazole On Formulary
CF Prescribing Pathway Final Version 5 Dec 2015 SCG

Cystic Fibrosis & non-CF Prescribing Pathway

Barts Health Oral Proton Pump Inhibitor use in Children Guideline

LANSOPRAZOLE

https://pathways.nice.org.uk/pathways/acute-upper-gastrointestinal-bleeding

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached

  Orodispersible tablet
Zoton FasTab (Pfizer Ltd) On Formulary
The Association of Paediatric Palliative Medicine Formulary - 2015

Barts Health Oral Proton Pump Inhibitor use in Children Guideline

Zoton®

Alternative to lansoprazole capsules

See PPI protocol

  omeprazole On Formulary
Barts Health Paediatric H pylori eradication Guideline

Seek advice from tertiary Paediatric Gastro team before initiating H pylori eradication treatment.

Barts Health Oral Proton Pump Inhibitor use in Children Guideline

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

CF Prescribing Pathway Final Version 5 Dec 2015 SCG

Cystic Fibrosis & non-CF Prescribing Pathway

The Association of Paediatric Palliative Medicine Formulary - 2017

see attached 

OMEPRAZOLE

For NICE guidance on management of upper GI bleeding in children over 16 years:

https://pathways.nice.org.uk/pathways/acute-upper-gastrointestinal-bleeding

  sodium alginate with calcium carbonate and sodium bicarbonate
  Oral suspension
Sodium alginate with calcium carbonate and sodium bicarbonate (Non-proprietary) On Formulary
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH

Peptac (Teva UK Ltd) On Formulary
Cystic Fibrosis & non-CF Prescribing Pathway

CF & non-CF Prescribing Pathway

Peptac®

For primary care only

Gastro-intestinal system / Rectal and anal disorders
  diltiazem hydrochloride On Formulary
  Modified-release tablet
Diltiazem hydrochloride (Non-proprietary) On Formulary
Retalzem (Kent Pharma (UK) Ltd) On Formulary
Tildiem (Sanofi) On Formulary
Tildiem Retard (Sanofi) On Formulary